Home0460 • HKG
Sihuan Pharmaceutical Holdings Group Ltd
$0.53
Mar 28, 4:08:03 PM GMT+8 · HKD · HKG · Disclaimer
StockHK listed security
Previous close
$0.57
Day range
$0.53 - $0.57
Year range
$0.49 - $0.88
Market cap
4.94B HKD
Avg Volume
6.56M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Jun 2023Y/Y change
Revenue
527.85M-27.90%
Operating expense
343.61M-26.03%
Net income
-24.82M-222.95%
Net profit margin
-4.70-270.29%
Earnings per share
EBITDA
84.46M-29.01%
Effective tax rate
-259.84%
Total assets
Total liabilities
(CNY)Jun 2023Y/Y change
Cash and short-term investments
4.51B-14.03%
Total assets
11.77B-18.30%
Total liabilities
6.52B3.39%
Total equity
5.25B
Shares outstanding
9.28B
Price to book
1.21
Return on assets
0.64%
Return on capital
1.15%
Net change in cash
(CNY)Jun 2023Y/Y change
Net income
-24.82M-222.95%
Cash from operations
14.16M-92.45%
Cash from investing
50.18M121.24%
Cash from financing
-111.76M54.31%
Net change in cash
-47.42M83.84%
Free cash flow
-8.39M87.32%
About
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market. Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
Founded
2001
Employees
3,241
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu